De-escalation of the antithrombotic therapy is independently associated with low risk of total mortality in patients with acute coronary syndrome (ACS) in real practice

2 March 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 3 - Acute Coronary Syndromes: Pharmacotherapy Pharmacotherapy ACVC Premium Access Acute Cardiovascular Care 2019

ESC 365 is supported by

ESC 365 is supported by